Investigational Product Immune12
What is Immune12 ?
Investigational product Immune12 is a proprietary complex biologic derived from specific marine-sourced ingredients. It is currently being evaluated by PMB for its potential to revolutionize cancer treatment in the areas of efficacy, safety and delivery. While current cancer treatments can be successful in extending life by several months they are not curative, risky and often have debilitating side effects. With its formulation, Immune12 is being evaluated for potential:
- Effectiveness in lowering GBM tumor growth and development beyond the current standard of care (SOC)
- Anti-cancer properties - killing cancer cells and reducing tumors after use
- Low negative side effects, especially as compared to the current SOC.
- Ability to administer in any environment, even at home.
Immune12 Key Ingredients
Interested in Clinical Trial Participation?
Patients, Health Care Professionals and Researchers interested in participating in our clinical trials can contact the clinical trial sites for eligibility criteria and enrollment information. We will also share details about the trial sites and contact information here, on our website. And of course, you may Contact Us. Australia Australia
Availability of Immune12
Investigational Product Immune12 is currently not available to the general public.
What is Immune12 made from?
Immune12 is a complex biologic made in a proprietary formulation with 2 types of warm water sea cucumber, sea urchin, sea squirt, sargassum (a type of free-floating sea grass), and water. For more details contact us.
Where and How is Immune12 produced?
Immune12 is produced by Unicorn Pacific at their facility in Vanuatu in the South Pacific. Unicorn Pacific was founded in 1982 and is a leader in marine biotechnology. Utilizing a patented proprietary formula the raw materials are processed individually to extract the necessary active ingredients, remove toxins then blended and